Live Quote · NASDAQIMNMHealthcare· Biotechnology

Immunome, Inc.

$15.69▼ 5.54%($-0.92)
MKT CAP $1.85BNEXT EARNINGS Mar 2, 2027
50%
Bullish
TickerSpark Score
50/100
▌ Mixed
60
Valuation
20
Profitability
55
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMNM research report →

Analyst Price Target
$32.40+106.5% vs. today

Range $24 – $37

Analyst RatingBuy
13 Buy1 Hold0 Sell

Price Chart

-6.11% · this period
$29.83$23.15$16.47Nov 19May 22Nov 19
52-Week Range1% of range
Low
$15.55
Current
$15.69
High
$30.06